{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:59:51Z","timestamp":1793818791212,"version":"4.6.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.htct.2025.106087","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:50:06Z","timestamp":1763643006000},"page":"106087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Lymphoma-associated hemophagocytic lymphohistiocytosis"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4448-9595","authenticated-orcid":false,"given":"Thom\u00e1s de Souza Patto","family":"Marcondes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4639-2578","authenticated-orcid":false,"given":"Carlos S\u00e9rgio","family":"Chiattone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9480-4995","authenticated-orcid":false,"given":"Rafael Dezen","family":"Gaiolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.htct.2025.106087_bib0001","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.htct.2025.106087_bib0002","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0003","unstructured":"Berliner H.A.S.N. Hemophagocytic lymphohistiocytosis. 2017;23."},{"key":"10.1016\/j.htct.2025.106087_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","article-title":"Hemophagocytic lymphohistiocytosis","volume":"13","author":"Al-Samkari","year":"2018","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"10.1016\/j.htct.2025.106087_bib0005","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/ard-2023-224123","article-title":"The 2022 EULAR\/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis\/macrophage activation syndrome (HLH\/MAS)","volume":"82","author":"Shakoory","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.htct.2025.106087_bib0006","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/bjh.13837","article-title":"Haemophagocytic lymphohistiocytosis in adults: a multicentre case series over 7 years","volume":"172","author":"Schram","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2025.106087_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2020.101515","article-title":"Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy","volume":"34","author":"Griffin","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.htct.2025.106087_bib0008","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/asheducation-2015.1.177","article-title":"Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis","volume":"2015","author":"Allen","year":"2015","journal-title":"Hematology"},{"key":"10.1016\/j.htct.2025.106087_bib0009","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/10428194.2010.551153","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in adults: a retrospective population-based analysis from a single center","volume":"52","author":"Machaczka","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.htct.2025.106087_bib0010","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/blood.2023020715","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in Sweden: incidence, clinical characteristics, and survival","volume":"143","author":"L\u00f6fstedt","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0011","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0012","doi-asserted-by":"crossref","first-page":"59977","DOI":"10.18632\/oncotarget.19230","article-title":"A systematic review of malignancy-associated hemophagocytic lymphohistiocytosis that needs more attentions","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.htct.2025.106087_bib0013","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/bjh.17638","article-title":"Haemophagocytic lymphohistiocytosis and Epstein\u2013Barr virus: a complex relationship with diverse origins, expression and outcomes","volume":"196","author":"El-Mallawany","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2025.106087_bib0014","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3324\/haematol.10829","article-title":"Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions","volume":"92","author":"Ferreri","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.htct.2025.106087_bib0015","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S2352-3026(21)00366-5","article-title":"Malignancy-associated haemophagocytic lymphohistiocytosis","volume":"9","author":"Setiadi","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.htct.2025.106087_bib0016","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3390\/cancers15061839","article-title":"Diagnosis and management of adult malignancy-associated hemophagocytic lymphohistiocytosis","volume":"15","author":"Lee","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.htct.2025.106087_bib0017","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4037\/aacnacc2019463","volume":"30","author":"Skinner","year":"2019","journal-title":"AACN Adv Crit Care"},{"key":"10.1016\/j.htct.2025.106087_bib0018","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/bloodadvances.2020001605","article-title":"Frequency and spectrum of disease-causing variants in 1892 patients with suspected genetic HLH disorders","volume":"4","author":"Gadoury-Levesque","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.htct.2025.106087_bib0019","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1002\/cncr.30826","article-title":"A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults","volume":"123","author":"Daver","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.htct.2025.106087_bib0020","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0021","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood.2019003664","article-title":"Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect","volume":"136","author":"Carvelli","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0022","doi-asserted-by":"crossref","first-page":"e198","DOI":"10.1016\/j.clml.2020.10.009","article-title":"Clinical characteristics of hemophagocytic lymphohistiocytosis associated with non-hodgkin B-cell lymphoma: a multicenter retrospective study","volume":"21","author":"Li","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.htct.2025.106087_bib0023","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41375-024-02135-8","article-title":"Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis","volume":"38","author":"Knauft","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.htct.2025.106087_bib0024","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1182\/blood-2015-01-551622","article-title":"How I treat hemophagocytic lymphohistiocytosis in the adult patient","volume":"125","author":"Schram","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0025","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1086\/345903","article-title":"Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin","volume":"36","author":"Palazzi","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.htct.2025.106087_bib0026","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.htct.2025.106087_bib0027","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0028","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome: score for reactive hemophagocytic Syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.htct.2025.106087_bib0029","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/ajcp\/aqw076","article-title":"Performances of the H-score for diagnosis of hemophagocytic lymphohistiocytosis in adult and pediatric patients","volume":"145","author":"Debaugnies","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.htct.2025.106087_bib0030","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1182\/blood-2020-138589","article-title":"External validation of the HLH-2004 diagnostic criteria and H-score for diagnosis of hemophagocytic lymphohistiocytosis in adults","volume":"136","author":"Croden","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0031","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/cncr.30084","article-title":"Malignancy-associated hemophagocytic lymphohistiocytosis in adults: relation to hemophagocytosis, characteristics, and outcomes","volume":"122","author":"Tamamyan","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.htct.2025.106087_bib0032","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1182\/blood.2021012764","article-title":"An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis","volume":"139","author":"Zoref-Lorenz","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0033","doi-asserted-by":"crossref","first-page":"7258","DOI":"10.1182\/bloodadvances.2023010546","article-title":"Early response markers predict survival after etoposide-based therapy of hemophagocytic lymphohistiocytosis","volume":"7","author":"Verkamp","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.htct.2025.106087_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1210041","article-title":"Approaching hemophagocytic lymphohistiocytosis","volume":"14","author":"Chinnici","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.htct.2025.106087_bib0035","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/CCM.0000000000005361","article-title":"Consensus-based guidelines for the recognition, diagnosis, and management of hemophagocytic lymphohistiocytosis in critically ill children and adults","volume":"50","author":"Hines","year":"2022","journal-title":"Crit Care Med"},{"key":"10.1016\/j.htct.2025.106087_bib0036","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jaip.2018.05.031","article-title":"Recommendations for the use of etoposide-based therapy and bone marrow transplantation for the treatment of HLH: consensus statements by the HLH Steering Committee of the Histiocyte Society","volume":"6","author":"Ehl","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.htct.2025.106087_bib0037","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1080\/10428194.2020.1737684","article-title":"Clinical outcomes of adults with hemophagocytic lymphohistiocytosis treated with the HLH-04 protocol: a retrospective analysis","volume":"61","author":"Bubik","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.htct.2025.106087_bib0038","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/JBM.S46255","article-title":"Hemophagocytic lymphohistiocytosis: review of etiologies and management","author":"George","year":"2014","journal-title":"J Blood Med"},{"key":"10.1016\/j.htct.2025.106087_bib0039","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s12032-014-0902-y","article-title":"Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China","volume":"31","author":"Li","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.htct.2025.106087_bib0040","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00277-013-1784-3","article-title":"Lymphoma-associated hemophagocytic lymphohistiocytosis: experience in adults from a single institution","volume":"92","author":"Yu","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.htct.2025.106087_bib0041","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00432-020-03376-7","article-title":"Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer\/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis","volume":"147","author":"Wei","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.htct.2025.106087_bib0042","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00277-020-04093-4","article-title":"Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis\u2014A dangerous disease","volume":"99","author":"Jin","year":"2020","journal-title":"Ann Hematol"},{"key":"10.1016\/j.htct.2025.106087_bib0043","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/10245332.2017.1385191","article-title":"Multivariate analysis of prognosis for patients with natural killer\/T cell lymphoma-associated hemophagocytic lymphohistiocytosis","volume":"23","author":"Jin","year":"2018","journal-title":"Hematology"},{"key":"10.1016\/j.htct.2025.106087_bib0044","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1532\/IJH97.07012","article-title":"Nationwide Survey of hemophagocytic lymphohistiocytosis in Japan","volume":"86","author":"Ishii","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.htct.2025.106087_bib0045","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.3324\/haematol.2019.220301","article-title":"Dose-adjusted EPOCH regimen as first-line treatment for non-hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial","volume":"105","author":"Liang","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.htct.2025.106087_bib0046","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0047","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0048","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-med-042921-112837","article-title":"Cytokine Storm Syndrome","volume":"74","author":"Cron","year":"2023","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.htct.2025.106087_bib0049","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/15384047.2021.1996139","article-title":"Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis","volume":"22","author":"Song","year":"2021","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.htct.2025.106087_bib0050","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/bjh.15506","article-title":"A comprehensive analysis of Lymphoma-associated haemophagocytic syndrome in a large French multicentre cohort detects some clues to improve prognosis","volume":"183","author":"Bigenwald","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.htct.2025.106087_bib0051","doi-asserted-by":"crossref","DOI":"10.1177\/09636897211057077","article-title":"Autologous hematopoietic stem cell transplantation for patients with lymphoma-associated hemophagocytic lymphohistiocytosis","volume":"30","author":"Song","year":"2021","journal-title":"Cell Transplant"},{"key":"10.1016\/j.htct.2025.106087_bib0052","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.614704","article-title":"Use of the JAK inhibitor Ruxolitinib in the treatment of hemophagocytic lymphohistiocytosis","volume":"12","author":"Keenan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.htct.2025.106087_bib0053","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","article-title":"Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial","volume":"6","author":"Ahmed","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.htct.2025.106087_bib0054","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.seminhematol.2018.07.006","article-title":"Low dose ruxolitinib plus HLH-94 protocol: a potential choice for secondary HLH","volume":"57","author":"Wang","year":"2020","journal-title":"Semin Hematol"},{"key":"10.1016\/j.htct.2025.106087_bib0055","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/ejh.13593","article-title":"Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: a case series","volume":"106","author":"Hansen","year":"2021","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.htct.2025.106087_bib0056","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1007\/s00432-020-03301-y","article-title":"Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome","volume":"146","author":"Zhou","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.htct.2025.106087_bib0057","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s10875-017-0439-x","article-title":"A personalized diagnostic and treatment approach for macrophage activation syndrome and secondary hemophagocytic lymphohistiocytosis in adults","volume":"37","author":"Kumar","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.htct.2025.106087_bib0058","doi-asserted-by":"crossref","first-page":"5799","DOI":"10.3390\/jcm11195799","article-title":"Anakinra for the treatment of hemophagocytic lymphohistiocytosis: 21 cases","volume":"11","author":"Baverez","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.htct.2025.106087_bib0059","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s13023-022-02516-1","article-title":"Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study","volume":"17","author":"Kim","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.htct.2025.106087_bib0060","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.htct.2025.106087_bib0061","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy \u2014 Assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.htct.2025.106087_bib0062","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2015-05-644914","article-title":"Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0063","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1182\/blood.2019002289","article-title":"Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis","volume":"134","author":"Vallurupalli","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.htct.2025.106087_bib0064","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2023.284179","article-title":"Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis","author":"Johnson","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.htct.2025.106087_bib0065","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.bbmt.2018.11.032","article-title":"Fludarabine\/Melphalan 100 mg\/m2 conditioning therapy followed by allogeneic hematopoietic cell transplantation for adult patients with secondary hemophagocytic lymphohistiocytosis","volume":"25","author":"Park","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.htct.2025.106087_bib0066","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1182\/bloodadvances.2022007012","article-title":"Favorable outcomes following allogeneic transplantation in adults with hemophagocytic lymphohistiocytosis","volume":"7","author":"Gooptu","year":"2023","journal-title":"Blood Adv"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925023545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137925023545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:38:21Z","timestamp":1774701501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137925023545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2531137925023545"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2025.106087","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphoma-associated hemophagocytic lymphohistiocytosis","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2025.106087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106087"}}